akhatri

Following a decision taken by Eli Lilly to increase its UK list prices for Mounjaro® (Tirzepatide) KwikPen® from 1 September 2025, the Department of Health and Social Care (DHSC) has re-determined the NHS reimbursement prices for all strengths of Mounjaro® dispensed from September to reflect the new, higher list prices. To avoid pharmacy owners dispensing [...]

The post Mounjaro® reimbursement prices redetermined for September 2025 appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Notification: Various Products (Ipca Laboratories UK Limited) Date issued: 26 August 2025 Ipca Laboratories UK Ltd has informed the MHRA that the Patient Information Leaflet (PIL) in the products listed in this notification do not contain all the required safety information. DMRC reference number: DMRC-35766519 Marketing Authorisation Holder: Ipca Laboratories UK [...]

The post MHRA Class 4 Medicines Notification Various Products (Ipca Laboratories UK Limited) appeared first on Community Pharmacy England.

As part of our Funding & Reimbursement Shorts  series, Community Pharmacy England’s in-house Drug Tariff and funding experts have created a new video on the end of month submission process. For the end-of-month submission, pharmacy teams are required to declare the month’s dispensing activity by completing the FP34C form on the Manage Your Service (MYS) portal. [...]

The post Funding & Reimbursement Shorts: End of month submission process appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has published details of its ongoing work and plans to improve the management of medicines supply issues. This includes a commitment to consulting on the introduction of pharmacist flexibilities to supply alternatives when a medicine is in short supply. The new policy paper, Managing a robust and [...]

The post DHSC outlines work to improve medicines supply appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Defect Notification: Topiramate Zydus Pharmaceuticals UK 20mg/ml Oral Solution, Zydus Pharmaceuticals UK Ltd Drug alert number: EL(25)A/39 Date issued: 07 August 2025 Zydus Pharmaceuticals UK LTD has informed the MHRA that there is an error on the artwork for the outer carton and Patient Information Leaflet (PIL) of Topiramate Zydus Pharmaceuticals UK [...]

The post Class 4 Medicines Defect Notification: Topiramate Zydus Pharmaceuticals UK 20mg/ml Oral Solution, Zydus Pharmaceuticals UK Ltd appeared first on Community Pharmacy England.